# Previse funding: rounds and investors > Previse has raised $23M across 4 rounds since 2018. Investors include Bessemer Venture Partners, Gaingels and Tengxun Touzi. Every round with its source. Source: https://millionrounds.com/company/previse (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Funded startup](https://millionrounds.com/companies) # Who invested in *Previse* 4 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Fintech Funding summary Updated 26 Oct 2026 **$23M** raised across 4 rounds since 2018, from 4 sources **$7.0M** Series A **$13M** Series B **$1.1M** Round **$1.8M** Grant - **Latest round:** Grant, $1.8M Oct 2024 - **Biggest round:** $13M Series B · Apr 2022 - **Step-up i:** 1.6× - **Investors:** 10 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2019 2020 2021 2022 2023 2024 **$7.0M** Series A **$13M** Series B **$1.1M** Round **$1.8M** Grant - **First round:** Series A, $7.0M - **Biggest round:** $13M - **Usual gap between rounds:** 2.1 years ## The rounds - **Oct 2024** Grant **$1.8M** *3 new* [Gaingels](https://millionrounds.com/fund/gaingels) [TEDCO](https://millionrounds.com/fund/tedco) [National Cancer Institute (NCI)](https://millionrounds.com/fund/national-cancer-institute-nci) Source recorded - **Sept 2022** Round **$1.1M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Apr 2022** Series B **$13M** *5 new* [Bessemer Venture Partners](https://millionrounds.com/fund/bessemer-venture-partners) [Tengxun Touzi](https://millionrounds.com/fund/tengxun-touzi) [Oryx Fund](https://millionrounds.com/fund/oryx-fund) [Founders Factory](https://millionrounds.com/fund/founder-s-factory) [MasterCard](https://millionrounds.com/fund/mastercard) Source recorded - **Aug 2018** Series A **$7.0M** *2 new* [Augmentum Fintech](https://millionrounds.com/fund/augmentum-fintech) Bessemer Venture Partners/ Hambro Perks Reported by FinSMEs ## Funding filed with regulators Previse filed one raise, $1.1M in all. Filings say how much was sold and to how many investors; they never name the investors. - Sept 2022 **$1.1M** UK share allotment ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2018 **Series B** 2022 **Round** 2022 **Grant** 2024 [Bessemer Venture Partners](https://millionrounds.com/fund/bessemer-venture-partners) [Gaingels](https://millionrounds.com/fund/gaingels) [Tengxun Touzi](https://millionrounds.com/fund/tengxun-touzi) [TEDCO](https://millionrounds.com/fund/tedco) [Oryx Fund](https://millionrounds.com/fund/oryx-fund) [Founders Factory](https://millionrounds.com/fund/founder-s-factory) [MasterCard](https://millionrounds.com/fund/mastercard) [National Cancer Institute (NCI)](https://millionrounds.com/fund/national-cancer-institute-nci) [Augmentum Fintech](https://millionrounds.com/fund/augmentum-fintech) Bessemer Venture Partners/ Hambro Perks ## Everyone who backed them [Bessemer Venture Partners](https://millionrounds.com/fund/bessemer-venture-partners) VC firm **1** round [Gaingels](https://millionrounds.com/fund/gaingels) Private equity **1** round [Tengxun Touzi](https://millionrounds.com/fund/tengxun-touzi) VC firm **1** round [TEDCO](https://millionrounds.com/fund/tedco) VC firm **1** round [Oryx Fund](https://millionrounds.com/fund/oryx-fund) VC firm **1** round [Founders Factory](https://millionrounds.com/fund/founder-s-factory) Accelerator **1** round [MasterCard](https://millionrounds.com/fund/mastercard) Corporate VC **1** round [National Cancer Institute (NCI)](https://millionrounds.com/fund/national-cancer-institute-nci) Investment firm **1** round [Augmentum Fintech](https://millionrounds.com/fund/augmentum-fintech) VC firm **1** round Bessemer Venture Partners/ Hambro Perks no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=previse). ## Also claim to have backed them These 2 firms list Previse as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [VentureFounders](https://millionrounds.com/fund/venturefounders) VC firm Per its own site [Reefknot Investments](https://millionrounds.com/fund/reefknot-investments) VC firm Per its own site ## Quick answers about Previse ### Who invested in Previse? Previse's investors include Bessemer Venture Partners, Gaingels, Tengxun Touzi, TEDCO and Oryx Fund, and 5 more on record. ### How much has Previse raised? Previse has raised $23M across 4 rounds since 2018. ### When did Previse last raise? Previse's most recent round was a Grant of $1.8M in Oct 2024. ### What was Previse's biggest round? Previse's largest round on record is $13M (Series B), in Apr 2022. ### Who backed Previse first? Previse's first round on record, in Aug 2018, was backed by Augmentum Fintech and Bessemer Venture Partners/ Hambro Perks. ### What stage is Previse at? Previse's latest named round is a Grant, in Oct 2024. ### Where is Previse based? Previse is based in the United Kingdom. ## Companies like Previse In the same sector, and raised in the last eighteen months. [**Cognitive Credit** $64M · Oct 2026](https://millionrounds.com/company/cognitive-credit)[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**Reactive Markets** Oct 2026](https://millionrounds.com/company/reactive-markets)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**TrueLayer** $376M · Oct 2026](https://millionrounds.com/company/truelayer) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app